-$219.9K
Net Activity
Institutions Holding
35
Popularity Rank
#6870
Avg Weight
0.00%
Total Value
$1.1M
35 institutions currently hold IGC, with 13 net buyers and 9 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
9
Net Buying Institutions
13
Top 5 by Value
+$325.6K
Total Buy Value
$412.4K
Total Sell Value
13
Net Buyers
9
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
IGC Pharma, Inc. furnished an updated investor presentation on July 13, 2026, which will be used in meetings with investors, analysts, and potential partners. The presentation is attached as Exhibit 99.1 to this 8-K filing.
View Full Filing (SEC EDGAR)IGC Pharma entered into stock purchase agreements with its CEO Ram Mukunda and VP Claudia Grimaldi. They bought shares at $0.27 per share using over $1.15 million in debt the company owed them, including personal cash advances and deferred amounts. The company issued roughly 4.27 million shares, reducing its liabilities by the same amount with no cash changing hands.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter